THC Diamonds

THCA Diamonds are the most chemically concentrated solid form of tetrahydrocannabinol available in the pharmaceutical and medical extraction sectors. In their raw botanical state, cannabis plants synthesize non-intoxicating THCA rather than Delta-9-THC. Through precise temperature, pressure, and solvent saturation control within specialized crystallization vessels (“diamond miners”), THCA precipitates out of solution to form dense, macroscopic crystal lattices while volatile terpenes and secondary cannabinoids remain in the liquid High Terpene Extract (HTE) mother liquor.

Once crystallized, the pure THCA structures are separated and subjected to extended vacuum purging to strip all trace hydrocarbons down to non-detectable levels. For pharmaceutical formulations and compounding laboratories across Europe—including Germany, the Czech Republic, and the UK—THCA Diamonds provide an unadulterated Active Pharmaceutical Ingredient (API) with zero terpene interference, allowing for exact milligram-level dosing in treating refractory pain, neurological conditions, and severe wasting syndromes.

Technical Specifications & Certificate of Analysis (CoA)

Specification	Standard / Analytical Value
Chemical Nomenclature	Tetrahydrocannabinolic Acid (THCA-A)
Product Classification	Crystalline Cannabinoid Isolate
THCA Potency	95.0% – 99.0%+ w/w
Active Delta-9 THC	< 1.0% w/w (Prior to thermal conversion)
Theoretical Decarbed THC	~83.3% – 86.8% w/w ( $THCA \times 0.877$ )
Minor Cannabinoids	CBG/CBGA (< 0.5%), CBD/CBDA (< 0.2%)
Residual Solvents	Non-detectable (< 0.5 ppm, Ph. Eur. 2.4.24)
Heavy Metal Analysis	Lead (< 0.5 ppm), Cadmium (< 0.2 ppm), Mercury (< 0.1 ppm), Arsenic (< 0.2 ppm)
Melting Point	155°C – 165°C (with simultaneous decarboxylation)
Moisture Content	< 0.5% (Ph. Eur. 2.2.32)
Manufacturing Standard	EU-GMP (Good Manufacturing Practice Part I & II)
Agricultural Standard	GACP Compliant Indoor Biomass Source
Pharmacopoeial Monograph	European Pharmacopoeia (Ph. Eur.) Compliant

Sensory, Physical & Thermal Performance Breakdown

Visual & Crystalline Matrix: Faceted, translucent-to-opaque mineral-like stones exhibiting natural diamond refraction; range from small 2 mm sugar gems to large 15 mm boulder formations.
Aroma & Flavor Profile: Odorless and flavor-neutral in isolated state due to complete removal of volatile terpenes; produces a smooth, non-irritating vapor stream free from plant chlorophylls and lipids.
Decarboxylation & Solubility: Instantly decarboxylates upon thermal contact ( $> 105^\circ\text{C}$ ) into active Delta-9-THC. Highly soluble in warm medium-chain triglycerides (MCT) and ethanol for clinical oral compounding.
Entourage Flexibility: Serves as a neutral, high-potency API that can be consumed pure or reintroduced to strain-specific botanical terpene blends for customized therapeutic profiles.

European Compliance, Quality Assurance & Distribution

EU-GMP Quality Assurance: Crystallized, isolated, and vacuum-purged in cleanroom facilities certified under EU-GMP standards, ensuring absolute batch repeatability and zero chemical adulteration.
ISO 17025 Accredited Laboratory Verification: Each production lot undergoes comprehensive analytical screening under Ph. Eur. Chapter 5.1.8 guidelines for residual solvents (gas chromatography-mass spectrometry), heavy metals, pesticides, mycotoxins, and microbial bioburden.
Schengen Cross-Border Distribution: Fully supported by commercial compliance files, including batch-specific CoAs, Active Pharmaceutical Ingredient (API) dossiers, and authorized bilateral import/export narcotics certificates for cross-border transit across the European Union.
Pharmaceutical Packaging: Packaged in medical-grade, ultraviolet-blocking amber glass containers or chemical-resistant PTFE-sealed jars protected with inert nitrogen flushing to eliminate oxidation and preserve crystal stability.